China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a report issued on Saturday. The brokerage set a “hold” rating on the stock.

China Pharma Price Performance

NYSE:CPHI opened at $0.20 on Friday. China Pharma has a 12-month low of $0.17 and a 12-month high of $0.74. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. The stock has a fifty day moving average price of $0.23 and a 200 day moving average price of $0.23.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.